Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$248.67 - $334.17 $21,136 - $28,404
85 New
85 $28,000
Q4 2020

Feb 09, 2021

SELL
$319.05 - $363.32 $265,449 - $302,282
-832 Closed
0 $0
Q3 2020

Nov 04, 2020

BUY
$280.08 - $347.78 $12,323 - $15,302
44 Added 5.58%
832 $280,000
Q2 2020

Jul 17, 2020

SELL
$270.93 - $320.3 $2,980 - $3,523
-11 Reduced 1.38%
788 $224,000
Q1 2020

Apr 16, 2020

SELL
$243.44 - $359.98 $1,460 - $2,159
-6 Reduced 0.75%
799 $220,000
Q4 2019

Feb 11, 2020

SELL
$281.18 - $322.05 $13,777 - $15,780
-49 Reduced 5.74%
805 $259,000
Q3 2019

Oct 15, 2019

SELL
$294.25 - $341.49 $14,418 - $16,733
-49 Reduced 5.43%
854 $254,000
Q3 2019

Oct 15, 2019

BUY
$294.25 - $341.49 $12,064 - $14,001
41 Added 4.76%
903 $230,000
Q2 2019

Aug 09, 2019

SELL
$279.29 - $336.89 $19,271 - $23,245
-69 Reduced 7.41%
862 $290,000
Q1 2019

May 07, 2019

BUY
$246.18 - $297.25 $229,193 - $276,739
931 New
931 $276,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Comerica Securities,Inc. Portfolio

Follow Comerica Securities,Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comerica Securities,Inc. with notifications on news.